Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
Migraine Again on MSN22h
What Is Aimovig for Migraine? Key Facts to Know About This Preventive TreatmentLearn how Aimovig for migraine works, how well it works, what to know before starting, and its possible side effects. Experts and community members also weigh in about their experiences with Aimovig.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback